Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,263 | 431 | 99.6% |
| Education | $26.06 | 5 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23.72 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,158 | 52 | $0 (2024) |
| Amgen Inc. | $1,850 | 52 | $0 (2024) |
| Novo Nordisk Inc | $1,812 | 68 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,427 | 42 | $0 (2024) |
| PFIZER INC. | $874.10 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $868.52 | 41 | $0 (2024) |
| Lilly USA, LLC | $627.82 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $347.70 | 14 | $0 (2022) |
| Merck Sharp & Dohme LLC | $239.70 | 15 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $192.21 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,949 | 42 | Boehringer Ingelheim Pharmaceuticals, Inc. ($432.18) |
| 2023 | $1,853 | 40 | Amgen Inc. ($587.13) |
| 2022 | $2,510 | 60 | Novo Nordisk Inc ($581.36) |
| 2021 | $1,638 | 59 | Boehringer Ingelheim Pharmaceuticals, Inc. ($364.95) |
| 2020 | $625.37 | 34 | PFIZER INC. ($99.20) |
| 2019 | $1,053 | 50 | Novo Nordisk Inc ($417.46) |
| 2018 | $1,362 | 69 | Janssen Pharmaceuticals, Inc ($233.22) |
| 2017 | $1,321 | 83 | AstraZeneca Pharmaceuticals LP ($297.19) |
All Payment Transactions
437 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $129.64 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $121.86 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: VACCINE | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $100.01 | General |
| Category: Neuromodulation | ||||||
| 08/27/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $15.41 | General |
| 07/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.72 | General |
| 07/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Obesity | ||||||
| 06/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: VACCINE | ||||||
| 06/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Inflammation | ||||||
| 05/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $120.30 | General |
| Category: DIABETES | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Inflammation | ||||||
| 03/20/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $105.60 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,965 | 4,582 | $936,263 | $343,298 |
| 2022 | 25 | 3,222 | 5,194 | $1.1M | $391,160 |
| 2021 | 24 | 3,071 | 4,472 | $858,168 | $332,000 |
| 2020 | 24 | 2,689 | 3,928 | $735,404 | $276,258 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 222 | 808 | $242,400 | $78,947 | 32.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 325 | 438 | $175,200 | $61,846 | 35.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 294 | 421 | $143,140 | $39,751 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 434 | $86,800 | $38,635 | 44.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 178 | 548 | $115,080 | $35,507 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 265 | 265 | $66,250 | $35,343 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 270 | $37,800 | $18,111 | 47.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 27 | 33 | $14,850 | $7,200 | 48.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 98 | 98 | $7,840 | $7,042 | 89.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 29 | 36 | $9,000 | $5,900 | 65.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $3,610 | $3,250 | 90.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 98 | 98 | $2,940 | $2,881 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 247 | 259 | $17,094 | $2,547 | 14.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 294 | 354 | $4,248 | $2,163 | 50.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,300 | $1,458 | 44.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 298 | 363 | $3,267 | $1,430 | 43.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $750.00 | $735.00 | 98.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 64 | 87 | $1,044 | $441.96 | 42.3% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 15 | 15 | $1,650 | $108.81 | 6.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 244 | 1,127 | $338,100 | $93,979 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 263 | 368 | $147,200 | $59,171 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 295 | 501 | $100,200 | $46,347 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 270 | 270 | $67,500 | $36,931 | 54.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 276 | 390 | $132,600 | $33,364 | 25.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 141 | 161 | $61,180 | $23,374 | 38.2% |
About Dr. John Gong, MD
Dr. John Gong, MD is a Internal Medicine healthcare provider based in Barrington, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962414623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Gong, MD has received a total of $12,312 in payments from pharmaceutical and medical device companies, with $1,949 received in 2024. These payments were reported across 437 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($12,263).
As a Medicare-enrolled provider, Gong has provided services to 11,947 Medicare beneficiaries, totaling 18,176 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Barrington, IL
- Active Since 08/12/2006
- Last Updated 06/12/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962414623
Products in Payments
- JARDIANCE (Drug) $2,092
- Otezla (Drug) $1,010
- Ozempic (Drug) $950.02
- FARXIGA (Drug) $936.07
- XARELTO (Drug) $735.40
- ELIQUIS (Drug) $450.72
- Repatha (Biological) $426.55
- TRULICITY (Drug) $326.16
- Aimovig (Biological) $299.74
- Rybelsus (Drug) $239.65
- BREZTRI (Drug) $220.55
- Saxenda (Drug) $172.92
- Tresiba (Drug) $165.87
- Vascepa (Drug) $160.70
- NURTEC ODT (Drug) $147.59
- Livalo (Drug) $143.60
- CHANTIX (Drug) $142.78
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $139.89
- SHINGRIX (Biological) $138.98
- INVOKANA (Drug) $133.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Barrington
Arthur Ostrowski, M.d, M.D
Internal Medicine — Payments: $14,317
Dr. Elizabeth Elliott, D.o, D.O
Internal Medicine — Payments: $5,787
Tasbirul Islam, Md, MD
Internal Medicine — Payments: $2,934
Allen Dennison, M.d, M.D
Internal Medicine — Payments: $2,904
Dr. Arvind Maheshwari, Md, MD
Internal Medicine — Payments: $1,981
Behzad Farah, Md, MD
Internal Medicine — Payments: $1,594